作者: Kevin X. Chen , Vishal A. Verma , Ashok Arasappan , F. George Njoroge
DOI:
关键词:
摘要: The present invention relates to 5′-Substituted Nucleoside Analogs of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, Z, R1, R2, R3 R3′ are as defined herein. also compositions comprising at least one Analog, methods using the for treating or preventing HCV infection in a patient.